Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC.

Luca Marzi; Andrea Mega; Stefano Gitto; Filippo Pelizzaro; Andreas Seeber; Gilbert Spizzo

doi:10.3390/cancers14143332

Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC.

Luca Marzi, Andrea Mega, Stefano Gitto, Filippo Pelizzaro, Andreas Seeber, Gilbert Spizzo

Krankenhaus Bozen

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

9 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Cancers
Jahrgang	14
Ausgabenummer	14
DOIs	https://doi.org/10.3390/cancers14143332
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.3390/cancers14143332

Dieses zitieren

@article{faacbc8db4d84ac18e69a1cca6e31ab3,

title = "Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC.",

keywords = "UNRESECTABLE HEPATOCELLULAR-CARCINOMA, TRANSARTERIAL CHEMOEMBOLIZATION, DOUBLE-BLIND, IMMUNOTHERAPY, SORAFENIB, ABLATION, PHASE-3, RESPONSES, RESECTION, THERAPY",

author = "Luca Marzi and Andrea Mega and Stefano Gitto and Filippo Pelizzaro and Andreas Seeber and Gilbert Spizzo",

note = "Lehr-KH Bozen: Marzi, Mega: Department of Gastroenterology, Bolzano Regional Hospital (SABES-ASDAA), 39100 Bolzano-Bozen, Italy; Lehr-KH Brixen: Spizzo: Department of Internal Medicine, Oncologic Day Hospital, Hospital of Bressanone (SABES-ASDAA), 39042 Bressanone-Brixen, Italy",

year = "2022",

doi = "10.3390/cancers14143332",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "14",

}

TY - JOUR

T1 - Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC.

AU - Marzi, Luca

AU - Mega, Andrea

AU - Gitto, Stefano

AU - Pelizzaro, Filippo

AU - Seeber, Andreas

AU - Spizzo, Gilbert

N1 - Lehr-KH Bozen: Marzi, Mega: Department of Gastroenterology, Bolzano Regional Hospital (SABES-ASDAA), 39100 Bolzano-Bozen, Italy; Lehr-KH Brixen: Spizzo: Department of Internal Medicine, Oncologic Day Hospital, Hospital of Bressanone (SABES-ASDAA), 39042 Bressanone-Brixen, Italy

PY - 2022

Y1 - 2022

KW - UNRESECTABLE HEPATOCELLULAR-CARCINOMA

KW - TRANSARTERIAL CHEMOEMBOLIZATION

KW - DOUBLE-BLIND

KW - IMMUNOTHERAPY

KW - SORAFENIB

KW - ABLATION

KW - PHASE-3

KW - RESPONSES

KW - RESECTION

KW - THERAPY

U2 - 10.3390/cancers14143332

DO - 10.3390/cancers14143332

M3 - Review article

C2 - 35884392

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 14

ER -